These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17236137)

  • 21. Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.
    Kokona B; Rigotti DJ; Wasson AS; Lawrence SH; Jaffe EK; Fairman R
    Biochemistry; 2008 Oct; 47(40):10649-56. PubMed ID: 18795796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phylogenetically conserved histidines of Escherichia coli porphobilinogen synthase are not required for catalysis.
    Mitchell LW; Volin M; Jaffe EK
    J Biol Chem; 1995 Oct; 270(41):24054-9. PubMed ID: 7592604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-onset porphyrias: what are they?
    Sassa S; Akagi R; Nishitani C; Harigae H; Furuyama K
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):97-101. PubMed ID: 11929054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and molecular characterization of a novel porphobilinogen synthase from Corynebacterium glutamicum.
    Zhu D; Wu C; Niu C; Li H; Ge F; Li W
    World J Microbiol Biotechnol; 2023 Apr; 39(6):165. PubMed ID: 37071336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental contaminants perturb fragile protein assemblies and inhibit normal protein function.
    Lawrence SH; Selwood T; Jaffe EK
    Curr Chem Biol; 2013; 7(2):196-206. PubMed ID: 25045409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual gene defects involving delta-aminolaevulinate dehydratase and coproporphyrinogen oxidase in a porphyria patient.
    Akagi R; Inoue R; Muranaka S; Tahara T; Taketani S; Anderson KE; Phillips JD; Sassa S
    Br J Haematol; 2006 Jan; 132(2):237-43. PubMed ID: 16398658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany.
    Doss MO; Stauch T; Gross U; Renz M; Akagi R; Doss-Frank M; Seelig HP; Sassa S
    J Inherit Metab Dis; 2004; 27(4):529-36. PubMed ID: 15303011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. delta-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote.
    Plewinska M; Thunell S; Holmberg L; Wetmur JG; Desnick RJ
    Am J Hum Genet; 1991 Jul; 49(1):167-74. PubMed ID: 2063868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.
    Yasuda M; Chen B; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):320-331. PubMed ID: 30594473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porphobilinogen synthase, the first source of heme's asymmetry.
    Jaffe EK
    J Bioenerg Biomembr; 1995 Apr; 27(2):169-79. PubMed ID: 7592564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphobilinogen synthase from pea: expression from an artificial gene, kinetic characterization, and novel implications for subunit interactions.
    Kervinen J; Dunbrack RL; Litwin S; Martins J; Scarrow RC; Volin M; Yeung AT; Yoon E; Jaffe EK
    Biochemistry; 2000 Aug; 39(30):9018-29. PubMed ID: 10913315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docking to large allosteric binding sites on protein surfaces.
    Ramirez UD; Myachina F; Stith L; Jaffe EK
    Adv Exp Med Biol; 2010; 680():481-8. PubMed ID: 20865533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plastid-associated porphobilinogen synthase from Toxoplasma gondii: kinetic and structural properties validate therapeutic potential.
    Shanmugam D; Wu B; Ramirez U; Jaffe EK; Roos DS
    J Biol Chem; 2010 Jul; 285(29):22122-31. PubMed ID: 20442414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activity of delta-aminolaevulinic acid (ALAD) in erythrocytes of patients with chronic hepatic porphyria (porphyria cutanea tarda)].
    Stankiewicz-Wróblewska J
    Pol Arch Med Wewn; 1993 Mar; 89(3):212-6. PubMed ID: 8100994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular mechanism of lead inhibition of human porphobilinogen synthase.
    Jaffe EK; Martins J; Li J; Kervinen J; Dunbrack RL
    J Biol Chem; 2001 Jan; 276(2):1531-7. PubMed ID: 11032836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of Toxoplasma gondii porphobilinogen synthase: insights on octameric structure and porphobilinogen formation.
    Jaffe EK; Shanmugam D; Gardberg A; Dieterich S; Sankaran B; Stewart LJ; Myler PJ; Roos DS
    J Biol Chem; 2011 Apr; 286(17):15298-307. PubMed ID: 21383008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel mutation of delta-aminolaevulinate dehydratase in a healthy child with 12% erythrocyte enzyme activity.
    Akagi R; Yasui Y; Harper P; Sassa S
    Br J Haematol; 1999 Sep; 106(4):931-7. PubMed ID: 10519994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bradyrhizobium japonicum porphobilinogen synthase uses two Mg(II) and monovalent cations.
    Petrovich RM; Litwin S; Jaffe EK
    J Biol Chem; 1996 Apr; 271(15):8692-9. PubMed ID: 8621501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse clinical compounds alter the quaternary structure and inhibit the activity of an essential enzyme.
    Lawrence SH; Selwood T; Jaffe EK
    ChemMedChem; 2011 Jun; 6(6):1067-73. PubMed ID: 21506274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracking the evolution of porphobilinogen synthase metal dependence in vitro.
    Frère F; Reents H; Schubert WD; Heinz DW; Jahn D
    J Mol Biol; 2005 Feb; 345(5):1059-70. PubMed ID: 15644204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.